Follow
Rodrigo Guindalini
Rodrigo Guindalini
Oncologia D'or
Verified email at oncologiador.com.br
Title
Cited by
Cited by
Year
The germline mutational landscape of BRCA1 and BRCA2 in Brazil
EI Palmero, DM Carraro, B Alemar, MAM Moreira, A Ribeiro-dos-Santos, ...
Scientific reports 8 (1), 9188, 2018
752018
Variation in the risk of colorectal cancer in families with Lynch syndrome: a retrospective cohort study
AK Win, JG Dowty, JC Reece, G Lee, AS Templeton, JP Plazzer, ...
The Lancet Oncology 22 (7), 1014-1022, 2021
632021
Germline mutations in BRCA1, BRCA2, CHEK2 and TP53 in patients at high-risk for HBOC: characterizing a Northeast Brazilian Population
GES Felix, C Abe-Sandes, T Machado-Lopes, TF Bomfim, RSC Guindalini, ...
Human genome variation 1 (1), 1-8, 2014
592014
Intensive Surveillance with Biannual Dynamic Contrast-Enhanced Magnetic Resonance Imaging Downstages Breast Cancer in BRCA1 Mutation Carriers
RSC Guindalini, Y Zheng, H Abe, K Whitaker, TF Yoshimatsu, T Walsh, ...
Clinical Cancer Research 25 (6), 1786-1794, 2019
572019
Monitoring survivin expression in cancer: implications for prognosis and therapy
RSC Guindalini, MC Mathias Machado, B Garicochea
Molecular diagnosis & therapy 17, 331-342, 2013
512013
Mutation spectrum and risk of colorectal cancer in African American families with Lynch syndrome
RSC Guindalini, AK Win, C Gulden, NM Lindor, PA Newcomb, RW Haile, ...
Gastroenterology 149 (6), 1446-1453, 2015
502015
Survival and prognosis of young adults with gastric cancer
MCV Cormedi, MLH Katayama, RSC Guindalini, SF Faraj, ...
Clinics 73, e651s, 2018
462018
Efficacy of anti-HER2 agents in combination with adjuvant or neoadjuvant chemotherapy for early and locally advanced HER2-positive breast cancer patients: a network meta-analysis
M Debiasi, CA Polanczyk, P Ziegelmann, C Barrios, H Cao, JJ Dignam, ...
Frontiers in Oncology 8, 156, 2018
362018
Supportive care in head and neck oncology
G de Castro Jr, RSC Guindalini
Current opinion in oncology 22 (3), 221-225, 2010
352010
Recommendations for advancing the diagnosis and management of hereditary breast and ovarian cancer in Brazil
MI Achatz, M Caleffi, R Guindalini, RM Marques, A Nogueira-Rodrigues, ...
JCO Global Oncology 6, 439-452, 2020
292020
Detection of germline variants in Brazilian breast cancer patients using multigene panel testing
RSC Guindalini, DV Viana, JPFW Kitajima, VM Rocha, RVM López, ...
Scientific reports 12 (1), 4190, 2022
262022
From colorectal cancer pattern to the characterization of individuals at risk: Picture for genetic research in Latin America
CA Vaccaro, F López‐Kostner, DV Adriana, EI Palmero, BM Rossi, ...
International journal of cancer 145 (2), 318-326, 2019
252019
Evaluation of the positioning of the tip of the Veress needle during creation of closed pneumoperitoneum in pigs
JLMC Azevedo, RSC Guindalini, AA Sorbello, CEP Silva, OC Azevedo, ...
Acta cirurgica brasileira 21, 26-30, 2006
25*2006
Genetic anticipation in BRCA1/BRCA2 families after controlling for ascertainment bias and cohort effect
RSC Guindalini, A Song, JD Fackenthal, OI Olopade, D Huo
Cancer 122 (12), 1913-1920, 2016
202016
Resistance to trastuzumab in HER2-positive mucinous invasive ductal breast carcinoma
Z Baretta, RSC Guindalini, G Khramtsova, OI Olopade
Clinical breast cancer 13 (2), 156-158, 2013
192013
Frequency of CDH1 germline variants and contribution of dietary habits in early age onset gastric cancer patients in Brazil
RSC Guindalini, MCV Cormedi, S Maistro, FS Pasini, PCAA Branas, ...
Gastric Cancer 22, 920-931, 2019
172019
Veress needle insertion in the left hypochondrium in creation of the pneumoperitoneum
OC Azevedo, JLMC Azevedo, AA Sorbello, GPS Miguel, RSC Guindalini, ...
Acta cirurgica brasileira 21, 296-303, 2006
172006
Personalizing precision oncology clinical trials in Latin America: an expert panel on challenges and opportunities
RJ Arai, RSC Guindalini, AS Llera, JM O'Connor, B Muller, M Lema, ...
The Oncologist 24 (8), e709-e719, 2019
162019
Validation of questionnaire on the Spiritual Needs Assessment for Patients (SNAP) questionnaire in Brazilian Portuguese
D de Araujo Toloi, D Uema, F Matsushita, PA da Silva Andrade, ...
ecancermedicalscience 10, 2016
152016
Criteria for eligibility to cisplatin in the curative treatment of head and neck cancer: consensus opinion from a panel of experts
G de Castro Jr, GV Alves, AF Castro, ALF Chaves, P De Marchi, ...
Critical Reviews in Oncology/Hematology 131, 30-34, 2018
132018
The system can't perform the operation now. Try again later.
Articles 1–20